Industry & Environment: 45%
Life Sciences: 35%
Resources: 20%

TOP 3 Markets:
Australia: 30%
North America: 25%
Europe: 20%

ALS Limited generates its revenues mainly from three major sectors: Industry & Environment, Life Sciences, and Resources. The largest share comes from the Industry & Environment sector, highlighting the importance of services such as environmental analysis and industrial testing.

Geographically, Australia is the largest market for ALS Limited, followed by North America and Europe. These markets significantly contribute to the total revenue and reflect the company's global presence and diversification.

Production Sites: Worldwide, with a focus on Australia, North America, Europe, and Asia.

ALS Limited is a globally operating company that primarily offers services in the field of testing, inspections, and certifications. The company operates numerous laboratories and production facilities around the world to provide its services in various industries such as mining, environment, food, and pharmaceuticals.

In Australia, the home country of ALS Limited, some of the most important laboratories and facilities are located. Furthermore, the company has expanded its presence in North America, Europe, and Asia to meet global requirements and offer its services in various markets.

Revenue Growth: 8.5% (2024)

Profit Growth: 7.2% (2024)

ALS Limited pursues a growth strategy focusing on geographical expansion and diversification of its service offerings. The company plans to strengthen its presence in emerging markets in Asia and Latin America to benefit from the increasing demand for its services in these regions.

In addition, ALS Limited is investing in technological innovations to make its laboratory services more efficient and accurate. This includes implementing advanced analytical technologies and digitizing processes to increase customer satisfaction and reduce operating costs.

Another focus is on strategic acquisitions to expand the service portfolio and tap into new market segments. This strategy is intended to complement organic growth and further strengthen ALS Limited's market position.

Raw Materials/Materials: Chemicals, Laboratory Equipment, Special Reagents
Main Import Countries: USA, Germany, China

ALS Limited, a leading company in the field of laboratory analysis and testing, imports a variety of raw materials and materials required for its services. These include in particular chemicals and special reagents used in the laboratories for analyses and tests.

The USA and Germany are significant suppliers of high-quality laboratory equipment and specialized chemicals. China also plays an important role, especially in supplying more cost-effective laboratory equipment and general chemicals. These import structures enable ALS Limited to offer its services worldwide at a high level of quality.

Market Share: Estimated 20% in the global TIC market (2025)
EBITDA Margin: 25% (2024)
R&D Investments: 5% of revenue (2024)

ALS Limited has a significant competitive advantage in the global Testing, Inspection, and Certification (TIC) market. With an estimated market share of 20%, the company is among the leading providers worldwide. This strong market position is supported by a robust EBITDA margin of 25%, indicating efficient operations and strong cost control.

Another important aspect of ALS Limited's competitive advantage is the continuous investment in research and development, accounting for approximately 5% of revenue. These investments enable the company to offer innovative solutions and adapt to changing market requirements.

In addition, ALS Limited benefits from a broad geographical presence and a diversified service portfolio, making the company more resilient to market fluctuations. Together, these factors significantly strengthen ALS Limited's competitive advantage in the TIC sector.

Institutional Investor Share: 65% (estimated, 2025)
Insider Buys/Sells: No significant transactions in the last year (estimated, 2025)

The institutional investor share in ALS Limited is estimated to be around 65%. This indicates a strong trust from institutional investors in the company, pointing to a stable financial performance and a solid business model.

There were no significant insider buys or sells in the last year, suggesting that the management and other insiders are satisfied with the current company strategy and do not expect any major changes in the ownership structure.

Market share of ALS Limited: 12% (2025, estimated)
Top competitors and their market shares:

1. SGS SA: 20%
2. Bureau Veritas: 18%
3. Intertek Group: 15%
4. ALS Limited: 12%
5. Eurofins Scientific: 10%
6. TÜV SÜD: 8%
7. Applus+: 7%
8. Dekra: 5%
9. Element Materials Technology: 3%
10. UL LLC: 2%

ALS Limited holds a significant market share of approximately 12% in the global testing, inspection, and certification industry. The largest competitor is SGS SA with a market share of 20%, followed by Bureau Veritas and Intertek Group.

The moat of ALS Limited primarily lies in their strong presence in mineral and environmental testing, where they offer specialized services. Their global infrastructure and technical expertise are also significant advantages.

Compared to competitors, the moat of ALS Limited is less pronounced than that of SGS SA and Bureau Veritas, which have a broader service portfolio and stronger global presence. These companies have a stronger moat due to their size and diversification, giving them a competitive advantage.

Revenue Growth: 9.8% (2024) Profit Growth: 11.5% (2024) Market Share in Testing, Inspection & Certification (TIC) Sector: 7% (2024)

In 2024, ALS Limited achieved a solid revenue growth of 9.8%, driven by strong demand in its core segments. The company has expanded its market presence in the Testing, Inspection & Certification (TIC) sector and now holds a market share of 7%.

The profit growth of 11.5% in 2024 indicates that ALS Limited is able to increase its profitability, pointing to efficient cost control and operational improvements. These positive developments could suggest that the stock presents an attractive investment opportunity, especially for investors interested in a company operating in a stable and growing market.

Additionally, in recent years, ALS Limited has invested in new technologies and services to further strengthen its market position. These strategic investments could lead to further growth and enhanced competitiveness in the long term.

Dividend Yield: 3.2% (2025, estimated)
Dividend History: Steady payout over the last 5 years

In recent years, ALS Limited has regularly distributed dividends, indicating a reliable dividend policy. The estimated dividend yield of 3.2% for the year 2025 shows that the company continues to strive to return a portion of its profits to its shareholders.

The continuity of dividend payments over the past five years indicates a stable financial position of the company. Analysts believe that ALS Limited will also be able to pay dividends in the future, provided that no significant negative market changes occur.